Compare Quest Diagnostics Inc (DGX) vs Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Roundhill Innov-100 0DTE Covered Call Strat ETF — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $30.48. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while Roundhill Innov-100 0DTE Covered Call Strat ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, Roundhill Innov-100 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.
| DGX | QDTE | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $216.02 | $36.60 |
52-Week Low | $166.42 | $26.85 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
QDTE (Roundhill Innovation-100 0DTE Covered Call Strategy ETF) trades at $29.98, down 1.69% with a bearish technical signal. The ETF employs a weekly covered call strategy on Nasdaq-100 components, generating high distribution yields through 0DTE options. Recent dividend payments show consistent weekly distributions, though the yield has compressed as volatility declined. Technical indicators show mixed signals with neutral oscillators but bearish moving averages.
The ETF faces headwinds from declining volatility reducing option premiums, potentially impacting future distribution rates. While the weekly income stream appeals to income investors, the strategy's sustainability depends on market conditions. Current technical weakness suggests near-term pressure, though the high-yield strategy remains attractive for income-focused portfolios in stable markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Roundhill Innov-100 0DTE Covered Call Strat ETF
QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on QDTE →
